Charles River Laboratories International In (CRL)

86.30
0.48 0.55
NYSE : Health Care
Prev Close 86.78
Open 86.85
Day Low/High 85.92 / 87.20
52 Wk Low/High 59.99 / 87.95
Volume 296.53K
Avg Volume 379.70K
Exchange NYSE
Shares Outstanding 47.18M
Market Cap 4.06B
EPS 3.20
P/E Ratio 26.30
Div & Yield N.A. (N.A)

Latest News

Charles River Laboratories Acquires Blue Stream Laboratories

Charles River Laboratories Acquires Blue Stream Laboratories

Charles River Laboratories International, Inc. (NYSE: CRL) today announced that it has acquired Blue Stream Laboratories, Inc.

Charles River Labs (CRL) Stock Falls, Credit Suisse Initiates Coverage

Charles River Labs (CRL) Stock Falls, Credit Suisse Initiates Coverage

Shares of Charles River Labs (CRL) fell this afternoon as Credit Suisse initiated coverage of the company with a 'neutral' rating.

Charles River Laboratories To Present At Jefferies And William Blair Conferences

Charles River Laboratories To Present At Jefferies And William Blair Conferences

Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at the Jefferies 2016 Global Healthcare Conference in New York, New York on Wednesday, June 8 th, at 10:00 a.

Moderna Therapeutics And Charles River Laboratories Announce Strategic Collaboration To Scale Moderna's Nonclinical Development Efforts For Novel MRNA Therapeutics

Moderna Therapeutics And Charles River Laboratories Announce Strategic Collaboration To Scale Moderna's Nonclinical Development Efforts For Novel MRNA Therapeutics

Moderna Therapeutics, a clinical stage pioneer in the development of messenger RNA (mRNA) Therapeutics™ and Charles River Laboratories International, Inc.

New Lifetime High Reached By Charles River Laboratories International In (CRL)

New Lifetime High Reached By Charles River Laboratories International In (CRL)

Trade-Ideas LLC identified Charles River Laboratories International In (CRL) as a new lifetime high candidate

Charles River Laboratories International In (CRL) Reaches New Lifetime High Today

Charles River Laboratories International In (CRL) Reaches New Lifetime High Today

Trade-Ideas LLC identified Charles River Laboratories International In (CRL) as a new lifetime high candidate

Charles River Laboratories International In (CRL) Reaches New Lifetime High Today

Charles River Laboratories International In (CRL) Reaches New Lifetime High Today

Trade-Ideas LLC identified Charles River Laboratories International In (CRL) as a new lifetime high candidate

Charles River Laboratories Announces First-Quarter 2016 Results From Continuing Operations

Charles River Laboratories Announces First-Quarter 2016 Results From Continuing Operations

Charles River Laboratories International, Inc. (NYSE: CRL) today reported its results for the first quarter of 2016.

Charles River Laboratories And BioMotiv Enter Into Strategic Partnership

Charles River Laboratories And BioMotiv Enter Into Strategic Partnership

Charles River Laboratories International, Inc. (NYSE: CRL) today announced that it has entered into a strategic partnership with BioMotiv, LLC, the therapeutic accelerator company associated with The Harrington Project for...

Charles River Laboratories Schedules First-Quarter 2016 Earnings Release And Conference Call

Charles River Laboratories Schedules First-Quarter 2016 Earnings Release And Conference Call

Charles River Laboratories International, Inc. (NYSE: CRL) will release first-quarter 2016 financial results on Wednesday, May 4 th before the market opens.

Charles River Laboratories Completes The Acquisition Of WIL Research

Charles River Laboratories Completes The Acquisition Of WIL Research

Charles River Laboratories International, Inc. (NYSE:CRL) announced today that it has completed the previously announced acquisition of WIL Research for approximately $585 million in cash, subject to certain customary...

Barbarian At The Gate: Charles River Laboratories International In (CRL)

Barbarian At The Gate: Charles River Laboratories International In (CRL)

Trade-Ideas LLC identified Charles River Laboratories International In (CRL) as a "barbarian at the gate" (strong stocks crossing above resistance with today's range greater than 200%) candidate

Short Interest Jumps 13% For CRL

Short Interest Jumps 13% For CRL

The most recent short interest data has been released by the NASDAQ for the 03/01/2016 settlement date, which shows a 272,521 share increase in total short interest for Charles River Laboratories International Inc. , to 2,346,986, an increase of 13.14% since 02/12/2016.

Charles River Laboratories To Present At Raymond James Conference

Charles River Laboratories To Present At Raymond James Conference

Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at the Raymond James 37 th Annual Institutional Investors Conference in Orlando, Florida on Tuesday, March 8 th, at 10:25 a.

Insider Trading Alert - CMS, CRL And LC Traded By Insiders

Insider Trading Alert - CMS, CRL And LC Traded By Insiders

Stocks with insider trader activity include CMS, CRL and LC

Charles River Laboratories International In (CRL) Stock Storming The Castle Today

Charles River Laboratories International In (CRL) Stock Storming The Castle Today

Trade-Ideas LLC identified Charles River Laboratories International In (CRL) as a "storm the castle" (crossing above the 200-day simple moving average on higher than normal relative volume) candidate

Charles River Laboratories Announces Fourth-Quarter And Full-Year 2015 Results From Continuing Operations And Provides 2016 Guidance

Charles River Laboratories Announces Fourth-Quarter And Full-Year 2015 Results From Continuing Operations And Provides 2016 Guidance

Charles River Laboratories International, Inc. (NYSE:CRL) today reported its results for the fourth-quarter and full-year 2015 and provided guidance for 2016.

Insider Trading Alert - CRL, BID And RTN Traded By Insiders

Insider Trading Alert - CRL, BID And RTN Traded By Insiders

Stocks with insider trader activity include CRL, BID and RTN

Today's Roof Leaker Stock Is Charles River Laboratories International In (CRL)

Today's Roof Leaker Stock Is Charles River Laboratories International In (CRL)

Trade-Ideas LLC identified Charles River Laboratories International In (CRL) as a "roof leaker" (crossing below the 200-day simple moving average on higher than normal relative volume) candidate

Charles River Laboratories Schedules Fourth-Quarter 2015 Earnings And 2016 Guidance Release And Conference Call

Charles River Laboratories Schedules Fourth-Quarter 2015 Earnings And 2016 Guidance Release And Conference Call

Charles River Laboratories International, Inc. (NYSE: CRL) will release fourth-quarter and full-year 2015 financial results and provide 2016 guidance on Wednesday, February 10th, before the market opens.

Charles River Laboratories International In (CRL) Spotted As Roof Leaker Today

Charles River Laboratories International In (CRL) Spotted As Roof Leaker Today

Trade-Ideas LLC identified Charles River Laboratories International In (CRL) as a "roof leaker" (crossing below the 200-day simple moving average on higher than normal relative volume) candidate

Jim Cramer's 'Mad Money' Recap: Here's This Week's Game Plan

Jim Cramer's 'Mad Money' Recap: Here's This Week's Game Plan

Investors need to sit back and wait for further weakness. So Cramer will be watching earnings from Alcoa and CSX but will be avoiding the banks.

Charles River Laboratories To Acquire WIL Research

Charles River Laboratories To Acquire WIL Research

Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it has entered into a definitive agreement to acquire WIL Research for approximately $585 million in cash, subject to customary closing...

Charles River Laboratories Expands Long-Standing Collaboration With The Michael J. Fox Foundation For Parkinson's Research

Charles River Laboratories Expands Long-Standing Collaboration With The Michael J. Fox Foundation For Parkinson's Research

Charles River Laboratories International, Inc. (NYSE: CRL) today announced a significant expansion of its work with small molecule LRRK2 inhibitors, funded by The Michael J.

Charles River Laboratories Acquires Oncotest GmbH

Charles River Laboratories Acquires Oncotest GmbH

Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it has acquired Oncotest GmbH, a Freiburg, Germany-based contract research organization (CRO) providing discovery services for oncology, one of...

Insider Trading Alert - CRL, TMO And CVLT Traded By Insiders

Insider Trading Alert - CRL, TMO And CVLT Traded By Insiders

Stocks with insider trader activity include CRL, TMO and CVLT

Charles River Laboratories Announces Third-Quarter 2015 Results From Continuing Operations

Charles River Laboratories Announces Third-Quarter 2015 Results From Continuing Operations

Charles River Laboratories International, Inc. (NYSE: CRL) today reported its results for the third quarter of 2015.